46 related articles for article (PubMed ID: 9354691)
1. A novel human cellular model of CDA IV enables comprehensive analysis revealing the molecular basis of the disease phenotype.
Ferrer-Vicens I; Ferguson DCJ; Wilson MC; Heesom KJ; Bieker JJ; Frayne J
Blood; 2023 Jun; 141(25):3039-3054. PubMed ID: 37084386
[TBL] [Abstract][Full Text] [Related]
2. Congenital dyserythropoietic anemia type II - a case report of two siblings in a family.
Singh KI; Shartsho JT; Singh WR; Devi RK; Singh AM
Indian J Hematol Blood Transfus; 2007 Dec; 23(3-4):116-8. PubMed ID: 23100929
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.
Iolascon A; Esposito MR; Russo R
Haematologica; 2012 Dec; 97(12):1786-94. PubMed ID: 23065504
[TBL] [Abstract][Full Text] [Related]
4. The COPII pathway and hematologic disease.
Khoriaty R; Vasievich MP; Ginsburg D
Blood; 2012 Jul; 120(1):31-8. PubMed ID: 22586181
[TBL] [Abstract][Full Text] [Related]
5. Congenital dyserythropoietic anaemias: new acquisitions.
Iolascon A; Russo R; Esposito MR; Piscopo C; Asci R; De Falco L; Di Noce F
Blood Transfus; 2011 Jul; 9(3):278-80. PubMed ID: 21251457
[No Abstract] [Full Text] [Related]
6. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.
Iolascon A; Russo R; Esposito MR; Asci R; Piscopo C; Perrotta S; Fénéant-Thibault M; Garçon L; Delaunay J
Haematologica; 2010 May; 95(5):708-15. PubMed ID: 20015893
[TBL] [Abstract][Full Text] [Related]
7. Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3.
Tamary H; Shalmon L; Shalev H; Halil A; Dobrushin D; Ashkenazi N; Zoldan M; Resnitzky P; Korostishevsky M; Bonne-Tamir B; Zaizov R
Am J Hum Genet; 1998 May; 62(5):1062-9. PubMed ID: 9545404
[TBL] [Abstract][Full Text] [Related]
8. Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II).
Iolascon A; Miraglia del Giudice E; Perrotta S; Granatiero M; Zelante L; Gasparini P
Blood; 1997 Nov; 90(10):4197-200. PubMed ID: 9354691
[TBL] [Abstract][Full Text] [Related]
9. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search.
Gasparini P; Miraglia del Giudice E; Delaunay J; Totaro A; Granatiero M; Melchionda S; Zelante L; Iolascon A
Am J Hum Genet; 1997 Nov; 61(5):1112-6. PubMed ID: 9345103
[TBL] [Abstract][Full Text] [Related]
10. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
Iolascon A; D'Agostaro G; Perrotta S; Izzo P; Tavano R; Miraglia del Giudice B
Haematologica; 1996; 81(6):543-59. PubMed ID: 9009444
[TBL] [Abstract][Full Text] [Related]
11. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25.
Lind L; Sandström H; Wahlin A; Eriksson M; Nilsson-Sojka B; Sikström C; Holmgren G
Hum Mol Genet; 1995 Jan; 4(1):109-12. PubMed ID: 7711721
[TBL] [Abstract][Full Text] [Related]
12. Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes.
Lanzara C; Ficarella R; Totaro A; Chen X; Roberto R; Perrotta S; Lasalandra C; Gasparini P; Iolascon A; Carella M
Blood Cells Mol Dis; 2003; 30(1):22-9. PubMed ID: 12667984
[TBL] [Abstract][Full Text] [Related]
13. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
Fukuda MN
Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
